TABLE 3.
Antidepressant drug–drug–drug interaction signals with semi‐Bayes shrunk adjusted rate ratios for unintentional traumatic injury greater than or equal to two, by antidepressant and therapeutic category of co‐dispensed drug
Antidepressant | Therapeutic class of co‐dispensed drug of the base‐pair | Co‐dispensed drug of the base‐pair | Candidate interacting precipitant | RR, semi‐Bayes shrunk and adjusted a | 95% CI |
---|---|---|---|---|---|
Amitriptyline | Cardiovascular | Losartan | Nitrofurantoin | 2.36 | 1.18–4.72 |
Endocrine and metabolic | Levothyroxine | Tizanidine | 2.31 | 1.34–3.99 | |
Levothyroxine | Celecoxib | 2.02 | 1.01–4.06 | ||
Bupropion | Cardiovascular | Losartan | Zolpidem | 2.07 | 1.13–3.80 |
Citalopram | Cardiovascular | Simvastatin | Sulfamethoxazole | 2.26 | 1.54–3.32 |
Simvastatin | Trimethoprim | 2.21 | 1.50–3.25 | ||
Atorvastatin | Cefuroxime | 2.44 | 1.29–4.62 | ||
Isosorbide mononitrate | Sulfamethoxazole | 2.20 | 1.25–3.88 | ||
Rosuvastatin | Sulfamethoxazole | 2.33 | 1.23–4.40 | ||
Rosuvastatin | Trimethoprim | 2.33 | 1.23–4.40 | ||
Isosorbide mononitrate | Trimethoprim | 2.11 | 1.20–3.69 | ||
Atenolol | Sulfamethoxazole | 2.01 | 1.13–3.56 | ||
Atenolol | Trimethoprim | 2.01 | 1.13–3.56 | ||
Lisinopril | Losartan | 2.06 | 1.11–3.80 | ||
Enalapril | Sulfamethoxazole | 2.19 | 1.04–4.63 | ||
Enalapril | Trimethoprim | 2.17 | 1.03–4.55 | ||
Central nervous system | Olanzapine | Lorazepam | 2.28 | 1.05–4.94 | |
Gabapentin | Buspirone | 2.24 | 1.22–4.13 | ||
Clonazepam | Tramadol | 2.10 | 1.24–3.57 | ||
Donepezil | Trimethoprim | 2.09 | 1.35–3.24 | ||
Donepezil | Sulfamethoxazole | 2.08 | 1.34–3.24 | ||
Memantine | Azithromycin | 2.07 | 1.08–3.96 | ||
Endocrine and metabolic | Norethindrone | Fluconazole | 2.94 | 1.43–6.06 | |
Ethinyl estradiol | Fluconazole | 2.67 | 1.31–5.44 | ||
Levothyroxine | Sulfamethoxazole | 2.38 | 1.73–3.29 | ||
Levothyroxine | Trimethoprim | 2.20 | 1.60–3.04 | ||
Levothyroxine | Tizanidine | 2.00 | 1.24–3.24 | ||
Renal and genitourinary | Finasteride | Sulfamethoxazole | 2.36 | 1.16–4.82 | |
Finasteride | Trimethoprim | 2.36 | 1.16–4.82 | ||
Tamsulosin | Amoxicillin | 2.23 | 1.36–3.66 | ||
Oxybutynin | Lisinopril | 2.19 | 1.25–3.84 | ||
Duloxetine | Cardiovascular | Carvedilol | Nitrofurantoin | 2.15 | 1.12–4.12 |
Losartan | Tamsulosin | 2.14 | 1.03–4.47 | ||
Simvastatin | Donepezil | 2.10 | 1.12–3.91 | ||
Central nervous system | Tizanidine | Dicyclomine | 2.63 | 1.31–5.27 | |
Zolpidem | Meloxicam | 2.27 | 1.33–3.89 | ||
Endocrine and metabolic | Allopurinol | Pregabalin | 2.58 | 1.19–5.60 | |
Gastrointestinal | Pantoprazole | Mirabegron | 2.16 | 1.03–4.52 | |
Hematological | Warfarin | Diazepam | 2.25 | 1.04–4.89 | |
Escitalopram | Cardiovascular | Simvastatin | Aripiprazole | 6.60 | 3.23–13.46 |
Olmesartan | Clonazepam | 4.35 | 2.09–9.07 | ||
Benazepril | Trimethoprim | 2.89 | 1.35–6.16 | ||
Rosuvastatin | Dexlansoprazole | 2.80 | 1.19–6.59 | ||
Atenolol | Sulfamethoxazole | 2.76 | 1.49–5.13 | ||
Atenolol | Trimethoprim | 2.76 | 1.49–5.13 | ||
Simvastatin | Pregabalin | 2.49 | 1.16–5.35 | ||
Pravastatin | Baclofen | 2.48 | 1.13–5.43 | ||
Benazepril | Sulfamethoxazole | 2.44 | 1.14–5.25 | ||
Terazosin | Alprazolam | 2.38 | 1.06–5.34 | ||
Simvastatin | Clonazepam | 2.34 | 1.38–3.97 | ||
Metoprolol | Naproxen | 2.15 | 1.32–3.52 | ||
Diltiazem | Doxycycline | 2.14 | 1.14–4.02 | ||
Atorvastatin | Carbidopa | 2.13 | 1.17–3.88 | ||
Atorvastatin | Levodopa | 2.13 | 1.17–3.88 | ||
Lisinopril | Divalproex | 2.03 | 1.05–3.92 | ||
Central nervous system | Memantine | Divalproex | 2.36 | 1.28–4.36 | |
Carbidopa | Sulfamethoxazole | 2.35 | 1.18–4.68 | ||
Carbidopa | Trimethoprim | 2.35 | 1.18–4.68 | ||
Levodopa | Sulfamethoxazole | 2.35 | 1.18–4.68 | ||
Levodopa | Trimethoprim | 2.35 | 1.18–4.68 | ||
Morphine | Ondansetron | 2.28 | 1.01–5.15 | ||
Gabapentin | Loperamide | 2.23 | 1.04–4.79 | ||
Ropinirole | Naproxen | 2.20 | 1.00–4.85 | ||
Clonazepam | Aripiprazole | 2.18 | 1.08–4.41 | ||
Risperidone | Tramadol | 2.08 | 1.02–4.25 | ||
Memantine | Furosemide | 2.04 | 1.22–3.42 | ||
Endocrine and metabolic | Levothyroxine | Aripiprazole | 2.94 | 1.63–5.29 | |
Levothyroxine | Sumatriptan | 2.15 | 1.09–4.24 | ||
Levothyroxine | Clonazepam | 2.14 | 1.41–3.24 | ||
Allopurinol | Sulfamethoxazole | 2.13 | 1.07–4.23 | ||
Allopurinol | Trimethoprim | 2.13 | 1.07–4.23 | ||
Alendronate | Trimethoprim | 2.10 | 1.05–4.19 | ||
Alendronate | Sulfamethoxazole | 2.07 | 1.03–4.15 | ||
Gastrointestinal | Ranitidine | Alprazolam | 2.13 | 1.12–4.05 | |
Hematological | Clopidogrel | Loperamide | 2.63 | 1.25–5.51 | |
Renal and genitourinary | Solifenacin | Sulfamethoxazole | 2.99 | 1.55–5.79 | |
Solifenacin | Trimethoprim | 2.84 | 1.46–5.51 | ||
Oxybutynin | Codeine | 2.62 | 1.26–5.46 | ||
Hydrochlorothiazide | Sulfamethoxazole | 2.46 | 1.61–3.77 | ||
Hydrochlorothiazide | Trimethoprim | 2.37 | 1.55–3.64 | ||
Fluoxetine | Cardiovascular | Pravastatin | Levofloxacin | 2.41 | 1.19–4.90 |
Diltiazem | Gabapentin | 2.10 | 1.01–4.37 | ||
Metoprolol | Sulfamethoxazole | 2.08 | 1.22–3.57 | ||
Central nervous system | Alprazolam | Fluconazole | 2.48 | 1.23–4.99 | |
Endocrine and metabolic | Metformin | Clonazepam | 2.74 | 1.40–5.36 | |
Gastrointestinal | Esomeprazole | Cyclobenzaprine | 2.18 | 1.08–4.39 | |
Renal and genitourinary | Triamterene | Oxycodone | 2.25 | 1.08–4.67 | |
Spironolactone | Amoxicillin | 2.23 | 1.04–4.78 | ||
Mirtazapine | Cardiovascular | Diltiazem | Amoxicillin | 2.92 | 1.55–5.50 |
Diltiazem | Clavulanate | 2.51 | 1.23–5.12 | ||
Pravastatin | Sulfamethoxazole | 2.22 | 1.08–4.55 | ||
Metoprolol | Cefdinir | 2.02 | 1.03–3.97 | ||
Digoxin | Tramadol | 2.00 | 1.08–3.70 | ||
Endocrine and metabolic | Levothyroxine | Risperidone | 2.09 | 1.11–3.94 | |
Paroxetine | Cardiovascular | Benazepril | Amoxicillin | 2.31 | 1.10–4.82 |
Lovastatin | Tramadol | 2.22 | 1.06–4.67 | ||
Losartan | Baclofen | 2.17 | 1.01–4.67 | ||
Amlodipine | Meclizine | 2.05 | 1.01–4.19 | ||
Endocrine and metabolic | Ethinyl estradiol | Cyclobenzaprine | 2.16 | 1.08–4.30 | |
Sertraline | Cardiovascular | Atenolol | Sulfamethoxazole | 2.63 | 1.54–4.51 |
Atenolol | Trimethoprim | 2.62 | 1.53–4.48 | ||
Diltiazem | Sulfamethoxazole | 2.55 | 1.40–4.65 | ||
Diltiazem | Trimethoprim | 2.44 | 1.34–4.42 | ||
Lisinopril | Loperamide | 2.41 | 1.33–4.38 | ||
Terazosin | Levofloxacin | 2.40 | 1.12–5.13 | ||
Atorvastatin | Ropinirole | 2.14 | 1.11–4.15 | ||
Diltiazem | Ondansetron | 2.01 | 1.10–3.69 | ||
Central nervous system | Clonazepam | Loperamide | 2.41 | 1.06–5.48 | |
Pregabalin | Doxycycline | 2.10 | 1.08–4.06 | ||
Meloxicam | Gabapentin | 2.07 | 1.17–3.68 | ||
Donepezil | Sulfamethoxazole | 2.04 | 1.24–3.34 | ||
Endocrine and metabolic | Levonorgestrel | Cyclobenzaprine | 2.32 | 1.01–5.31 | |
Levothyroxine | Megestrol | 2.11 | 1.15–3.88 | ||
Levothyroxine | Metolazone | 2.05 | 1.03–4.08 | ||
Allopurinol | Sulfamethoxazole | 2.02 | 1.08–3.77 | ||
Hematological | Warfarin | Sulfamethoxazole | 2.34 | 1.31–4.17 | |
Warfarin | Trimethoprim | 2.25 | 1.27–4.00 | ||
Warfarin | Gabapentin | 2.06 | 1.24–3.43 | ||
Clopidogrel | Quetiapine | 2.01 | 1.15–3.52 | ||
Renal and genitourinary | Solifenacin | Trimethoprim | 2.84 | 1.36–5.96 | |
Solifenacin | Sulfamethoxazole | 2.67 | 1.26–5.64 | ||
Oxybutynin | Trimethoprim | 2.31 | 1.31–4.08 | ||
Oxybutynin | Sulfamethoxazole | 2.29 | 1.29–4.07 | ||
Trazodone | Cardiovascular | Isosorbide mononitrate | Gabapentin | 2.51 | 1.24–5.09 |
Atorvastatin | Terbinafine | 2.41 | 1.12–5.17 | ||
Pravastatin | Alprazolam | 2.33 | 1.25–4.34 | ||
Atenolol | Sulfamethoxazole | 2.03 | 1.05–3.95 | ||
Central nervous system | Tramadol | Gabapentin | 2.04 | 1.14–3.66 | |
Quetiapine | Clonazepam | 2.03 | 1.07–3.86 | ||
Meloxicam | Gabapentin | 2.00 | 1.18–3.39 | ||
Endocrine and metabolic | Glimepiride | Meclizine | 2.15 | 1.01–4.59 | |
Renal and genitourinary | Spironolactone | Ciprofloxacin | 2.30 | 1.26–4.22 | |
Furosemide | Promethazine | 2.29 | 1.29–4.06 | ||
Respiratory | Montelukast | Promethazine | 2.13 | 1.00–4.54 | |
Venlafaxine | Cardiovascular | Simvastatin | Sulfamethoxazole | 2.11 | 1.12–3.97 |
Simvastatin | Trimethoprim | 2.06 | 1.10–3.86 | ||
Hematological | Clopidogrel | Methylprednisolone | 2.16 | 1.02–4.59 |
Abbreviations: CI, confidence interval; RR, rate ratio.
Rate ratio was calculated as outcome rates during candidate interacting precipitant‐exposed days divided by outcome rates during candidate interacting precipitant–unexposed days (i.e., ), adjusting for the following time‐varying covariates: average daily dose of antidepressant, follow‐up month, and ever having a prior traumatic injury of interest.